Orthopediatrics (KIDS) Free Cash Flow Growth (1y) (2017 - 2026)
Orthopediatrics (KIDS) Free Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | -14.34% |
| 10 | Orthopediatrics | 631.52 Mn | 585.64 Mn | 52.37 Mn | 77.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.59% |
| Mar 31, 2026 | 39.79% |
| Dec 31, 2025 | 659.97% |
| Sep 30, 2025 | 70.67% |
| Jun 30, 2025 | -8.85% |
| Mar 31, 2025 | 36.25% |
| Dec 31, 2024 | 50.62% |
| Sep 30, 2024 | -964.99% |
| Jun 30, 2024 | -27.81% |
| Mar 31, 2024 | -15.34% |
| Dec 31, 2023 | -204.58% |
| Sep 30, 2023 | 118.86% |
| Jun 30, 2023 | 25.61% |
| Mar 31, 2023 | -35.82% |
| Dec 31, 2022 | 351.32% |
| Sep 30, 2022 | -143.84% |
| Jun 30, 2022 | -25.58% |
| Mar 31, 2022 | -79.97% |
| Dec 31, 2021 | 31.88% |
| Sep 30, 2021 | 40.84% |